Agilent Technologies Thrives From the Forever Chemicals CrackdownAgilent Technologies Inc. (
NYSEA) is a diversified global leader in the life sciences, diagnostics and applied chemical markets.
Medical Stocks Waters, Agilent, Illumina Show Growth PotentialMedical-sector stocks Waters, Agilent, and Illumina appear to be trading at low valuations relative to their future growth prospects, according to analysts.
Waters Corporation Schedules First Quarter 2023 Earnings Conference Call
Waters Corporation (
NYSEWAT) will hold its Q1 2023 financial results conference call live on Tuesday, May 9th 2023 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters’ investor relations website at https://ir.waters.com. A replay of the webcast will also be available until at least May 23rd, 2023, at midnight eastern time.
Waters Launches its Most Sensitive and Compact Clinical IVD System with Xevo TQ Absolute IVD Mass Spectrometer
MSACL Conference 2023--Waters Corporation (
NYSEWAT) today unveiled its next generation Xevo TQ Absolute IVD mass spectrometer, expanding its family of MassTrak IVD LC-MS/MS Systems for clinical diagnostic applications.
Waters Corporation Appoints Richard Fearon to Board of Directors
Waters™ Corporation (
NYSEWAT) today announced the appointment of Richard Fearon to its Board of Directors, effective March 27, 2023. Mr. Fearon is the former Vice Chairman and Chief Financial and Planning Officer of Eaton Corporation, a multinational power management company.
Waters Introduces Next-Generation Alliance iS HPLC System Aimed at Reducing Up to 40% of Common Lab Errors
PITTCON 2023 – Waters Corporation (
NYSEWAT) today introduced Alliance iS, the next-generation intelligent HPLC System, designed to reduce compliance risk by adding new levels of proactive error detection, troubleshooting and ease-of-use. When combined with Waters’ compliance-ready Empower Chromatography Software and eConnect™ HPLC Columns, the Alliance iS High Performance Liquid Chromatography (HPLC) System streamlines the task of making accurate and precise measurements by detecting and eliminating common errors by up to 40%.i In doing so, the Alliance iS HPLC System helps QC laboratories consistently meet quality, safety, compliance, and on-time product delivery goals.
Waters’ New Battery Cycler Microcalorimeter Solution Accelerates Real-World Testing from Months to Weeks
PITTCON 2023 — Waters Corporation (
NYSEWAT) today announced a new Battery Cycler Microcalorimeter Solution from its TA Instruments™ Division for high-resolution characterization of battery cells. The instrument and software combination enables non-destructive testing under real-world operating conditions and significantly reduces experiment time from months to weeks, while providing decisive insights for greater battery efficiency, safety, and stability.
Waters Corporation Listed as No. 5 on Barron's 100 Most Sustainable Companies 2023 List
Waters Corporation’s (
NYSEWAT) companywide commitment to “leaving the world better than we found it” has earned it the number five ranking on the Barron’s 2023 100 Most Sustainable Companies U.S. list – its third consecutive year on the list, and its second time amongst the top ten.
Waters Corporation Presentation at the Cowen 43rd Annual Health Care Conference to be Webcast Live
Waters Corporation (
NYSEWAT) Udit Batra Ph.D., Waters’ President and Chief Executive Officer, will participate in a fireside chat at the Cowen Healthcare Conference on Monday, March 6th, 2023 at 9:50AM Eastern Time.
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2022 Financial Results
Waters Corporation (
NYSEWAT) today announced its financial results for the fourth quarter and full-year 2022.
Waters Corporation to Acquire Wyatt Technology, Light Scattering Instrument and Software Leader
Waters Corporation (
NYSEWAT) today announced it has entered into an agreement to acquire Wyatt Technology, a pioneer in innovative light scattering and field-flow fractionation instruments, software, accessories, and services, for $1.36 billion in cash, subject to certain adjustments. The transaction is expected to close in the second quarter of 2023, subject to regulatory approvals and other customary closing conditions.
New waters_connect System Monitoring Software Maximizes Productivity with Real-Time, Cloud-Native Lab Management
Waters Corporation (
NYSEWAT) today announced waters_connect™ System Monitoring, a new Software-as-a-Service (SaaS) application that enables laboratory managers and analysts to monitor the real-time status of any chromatography instruments, regardless of the manufacturer, running on Waters™ Empower™ Software.
Waters Corporation Schedules Fourth Quarter 2022 Earnings Conference Call
Waters Corporation (
NYSEWAT) will hold its Q4 2022 financial results conference call live on Wednesday, February 15th 2023 at 8:00 a.m. eastern time. A live webcast of the presentation will be available on Waters’ investor relations website at https://ir.waters.com. A replay of the webcast will also be available until at least March 1st, 2023, at midnight eastern time.
Waters Corporation Recognized for its Award-winning Products, Outstanding Leadership, and ESG Progress
Waters Corporation (
NYSEWAT) announced awards and recognitions from multiple independent industry organizations throughout 2022, highlighting strength and momentum of the company’s product portfolio, its culture, and leadership. Waters received more than 20 awards during the year that affirm the company’s position as a leading analytical tools and software provider committed to solving problems that matter.
Waters Corporation Presentation at the 41st Annual J.P. Morgan Healthcare Conference to Be Audio Webcast Live
Waters Corporation (
NYSEWAT) Udit Batra Ph.D., President and Chief Executive Officer, will speak to the investment community at the J.P. Morgan Healthcare Conference on Monday, January 9th, 2023 at 4:30PM Pacific Standard Time / 7:30PM Eastern Standard Time.
Waters Corporation Named to Dow Jones Sustainability Index for Second Consecutive Year
Waters Corporation (
NYSEWAT) announced it has been named to the Dow Jones Sustainability North America Index (DJSI North America) for the second consecutive year. The DJSI is informed by the S&P Global Corporate Sustainability Assessment (CSA), an annual evaluation of companies' sustainability practices.
Waters Corporation Appoints Dan Brennan and Mark Vergnano to Board of Directors
Waters Corporation (
NYSEWAT) today announced the appointment of Dan Brennan and Mark Vergnano, to its Board of Directors, effective November 23, 2022. Mr. Brennan currently serves as Executive Vice President and Chief Financial Officer of Boston Scientific Corporation, a global medical device company, and Mr. Vergnano is the former Chairman, President and Chief Executive Officer of The Chemours Company, a chemistry company.
Waters Introduces New PFAS Quantitation Workflow Enabled by Enhancements to waters_connect Informatics Platform
Waters Corporation (
NYSEWAT) today announced a new Per-and Polyfluoroalkyl Substances (PFAS) quantitation workflow enabled by enhancements to its waters_connect™ for quantitation software. Through a combination of Waters™ ultra-sensitive instrumentation, sample prep chemistries and software, the end-to-end workflow simplifies and automates the measurement of PFAS in food, soil, air, and water at parts-per-quadrillion levels that meet and exceed regulatory detection limits.
Waters Corporation Presentation at the Evercore ISI HealthconX 2022 Virtual Health Care Conference to Be Webcast Live
Waters Corporation (
NYSEWAT) Udit Batra Ph.D., President and Chief Executive Officer, will participate at the Evercore ISI HealthconX Conference virtually with a fireside on Tuesday, November 29th, 2022 from 1:00-1:45PM Eastern Standard Time.
Waters Highlights ESG Progress and New Commitments in its 2022 Report
Waters Corporation (
NYSEWAT) today released its 2022 Environmental, Social, and Governance (ESG) Report highlighting the company’s efforts for 2021 and the first half of 2022 to reduce its environmental footprint, develop a workforce that is more representative of the society we live in, and continue strong governance practices.
Waters Corporation (NYSE: WAT) Reports Third Quarter 2022 Financial Results
Waters Corporation (
NYSEWAT) today announced its financial results for the third quarter of 2022.
Waters Automates Solid Phase Extraction of Biological, Food and Environmental Samples with Andrew+ Pipetting Robot
Waters Corporation (
NYSEWAT) today introduced Extraction+ Connected Device, a new software-controlled product for the Waters™ Andrew+™ Pipetting Robot that automates the preparation of biological, food, forensics and environmental samples by solid phase extraction (SPE). The Extraction+ Connected Device eliminates the need to manually pipette and extract samples with a hands-free, automated approach to SPE. It can save scientists up to four hours of bench time for each sample set and reduce the risk of user-to-user variability.ii
Waters Marks 25 Years in Ireland with €6 Million Clinical Diagnostics R&D Center Expansion in Wexford
Waters Corporation (
NYSEWAT) today announced a combined investment of up to €6 million with support from IDA Ireland to expand its operations in Drinagh, Wexford to fund research and development (R&D) of new clinical diagnostics products. The operational expansion at the Wexford facility will create new scientific jobs through 2024.
Waters Corporation Schedules Third Quarter 2022 Earnings Conference Call
Waters Corporation (
NYSEWAT) will hold its Q3 2022 financial results conference call live on Tuesday, November 1st 2022 at 8:00 a.m. eastern time. A live webcast of the presentation will be available on Waters’ investor relations website at https://ir.waters.com. A replay of the webcast will also be available until at least November 15th, 2022, at midnight eastern time.
Waters Extends Capabilities of Flagship TA Instruments Rheometer for Efficient and Repeatable Powder Analysis
Waters Corporation (
NYSEWAT) today introduced new, innovative powder rheology tooling and software for its TA Instruments™ HR Rheometers allowing scientists to make preciseii, repeatable powder rheology measurements simpler and faster. Such measurements enable materials scientists to optimize the processing and end-use performance of powders used in batteries, pharmaceuticals, additive manufacturing, food, personal care products, and coatings.
